GENE ONLINE|News &
Opinion
Blog

Novo Nordisk
GeneOnline’s Weekly News Highlights: Aug 28-Sept 1
2023-09-05
Novo Nordisk Delivers Strong H1 Financial Performance, With Acquisition to Expand Weight Loss Market
2023-08-16
GeneOnline’s Weekly News Highlights: Aug 7-11
2023-08-14
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Novo Nordisk and Aspect Team Up to Develop Bioprinting-Based Diabetes Treatment
2023-04-13
Novo Nordisk Announces Major Insulin Price Cut by Up to 75%, Following in the Footsteps of Eli Lilly
2023-03-15
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
1 2
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top